Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
5 clusters · 11 sources · 46 days · First seen · Last updated
Schwab U.S. Dividend Equity ETF performance and strategy
Overview
Investors evaluating dividend-focused exchange-traded funds (ETFs) continue to weigh the Schwab U.S. Dividend Equity ETF (SCHD) against high-yield and growth-oriented alternatives. SCHD maintains a low-cost, lower-volatility profile with an expense ratio of 0.06% and a trailing 12-month yield of approximately 3.1%. This contrasts with the Fidelity High Dividend ETF (FDVV), which features a higher expense ratio of 0.15% and a more growth-oriented tilt toward technology and financial services. Additionally, high-yield option-income funds like SPYI and JEPQ offer distributions near 11% through call option sales, though these are often taxed as ordinary income, whereas SCHD’s qualified dividends typically benefit from long-term capital gains rates. SCHD has demonstrated strong performance, rising 27% over the past year and outperforming the Nasdaq 100’s 19% growth. This outperformance is linked to macroeconomic shifts where investors reduced multiples on large-cap AI-linked companies, benefiting SCHD’s lower technology weighting. A March index reconstitution shifted the portfolio toward sectors like healthcare, consumer goods, and energy, with major holdings including Qualcomm, Texas Instruments, and UnitedHealth. By August 2026, the fund continued this trend of outperformance. Reports indicate year-to-date gains of approximately 22.8%, with some data showing returns exceeding 29%, more than doubling the total return of the S&P 500. This success is attributed to SCHD’s multi-factor methodology—which selects companies based on consecutive dividend payments, free cash flow relative to debt, return on equity, and dividend growth—and a relatively low price-to-earnings ratio. Market conditions, including inflation concerns and higher interest rates, have further driven interest toward these value-oriented, high-quality dividend stocks over expensive growth and technology sectors. As of late September 2026, data highlights the long-term growth of the fund, noting that dividend payouts have nearly quadrupled since 2012.
Entities
Schwab U.S. Dividend Equity ETF · SPYI · S&P 500 · Dow Jones U.S. Dividend 100 Index · Amgen
Timeline
-
[BUSINESS] 2 sourcesSchwab U.S. Dividend Equity ETF payouts nearly quadruple since 2012
The Schwab U.S. Dividend Equity ETF (SCHD) has nearly quadrupled its dividend payout since 2012, driven by its index's strategy of selecting high-quality, dividend-growing companies.
-
[BUSINESS] 2 sourcesSchwab U.S. Dividend Equity ETF outperforms S&P 500 in 2026
The Schwab U.S. Dividend Equity ETF (SCHD) has significantly outperformed the S&P 500 in 2026, driven by a focus on value, quality, and high-dividend growth stocks amid shifting market preferences.
-
[BUSINESS] 2 sourcesSchwab U.S. Dividend Equity ETF sees significant inflows amid defensive shift
The Schwab U.S. Dividend Equity ETF (SCHD) has seen significant inflows as investors seek defensive assets, bolstered by strong performance in healthcare holdings like Merck & Co. and Amgen.
-
[BUSINESS] 3 sourcesSchwab U.S. Dividend Equity ETF outperforms Nasdaq 100
The Schwab U.S. Dividend Equity ETF (SCHD) has outperformed the Nasdaq 100 with a 27% annual rise, driven by sector rotation into healthcare and energy and its focus on durable dividend payers.
-
[BUSINESS] 5 sourcesDividend ETFs: Comparing SCHD growth strategy with high-yield options
Investors are evaluating dividend ETFs like SCHD, which prioritizes low costs and dividend growth, against high-yield option-income funds that offer larger monthly distributions but limited capital gains.
Sources
ad-hoc-news.de · brasilemfolhas.com · brasilemfolhas.com.br · cutthecrapinvesting.com · finanznachrichten.de · it-boltwise.de · lesgrandsmaitres.fr · otravel.com · seekingalpha.com · stocktitan.net · theascent.com
This summary has been updated 3 times: see revision history